Incremental benefits and cost of coordinated anxiety learning and management for anxiety treatment in primary care

Psychological Medicine

Volumn 42, Issue 9, 2012, Pages 1937-1948

  Joesch, J M ^a   Sherbourne, C D ^b   Sullivan, G ^c   Stein, M B ^d   Craske, M G ^e   Roy Byrne, P ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b RAND CORPORATION   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety disorders; collaborative care; incremental benefits and cost; primary care

Indexed keywords

ANXIOLYTIC AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PANIC; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNITED STATES;

ADULT; ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; COGNITIVE THERAPY; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; PANIC DISORDER; PHOBIC DISORDERS; PRIMARY HEALTH CARE; STRESS DISORDERS, POST-TRAUMATIC; TREATMENT OUTCOME; UNITED STATES;

EID: 84864562945     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291711002893     Document Type: Article

References (56)

1. Brazier JE, Roberts J (2004). The estimation of a preferencebased measure of health from the SF-12. Medical Care 42, 851-859.
2. Butler M, Kane RL, McAlpine D, Kathol RG, Fu SS, Hagedorn H, Wilt TJ (2008). Integration of Mental Health/Substance Abuse and Primary Care. Evidence Reports/Technology Assessments, No. 173. Agency for Healthcare Research and Quality (US) : Rockville, MD.
3. Campbell-Sills L, Norman SB, Craske MG, Sullivan G, Lang AJ, Chavira DA, Bystritsky A, Sherbourne CD, Roy-Byrne P, Stein MB (2009). Validation of a brief measure of anxiety-related severity and impairment: The Overall Anxiety Severity and Impairment Scale (OASIS). Journal of Affective Disorders 112, 92-101.
4. Craske MG, Rose RD, Lang AJ, Welch SS, Campbell-Sills L, Sullivan G, Sherbourne CD, Bystritsky A, Stein MB, Roy-Byrne PP (2009). Computer-assisted delivery of cognitive behavioral therapy for anxiety disorders in primary-care settings. Depression and Anxiety 26, 235-242.
5. Craske MG, Stein MB, Sullivan G, Sherbourne CD, Bystritsky A, Rose RD, Lang AJ, Welch SS, Campbell-Sills L, Golinelli D, Roy-Byrne P (2011). Disorder specific impact of CALM treatment for anxiety disorders in primary care. Archives of General Psychiatry 68, 378-388.
6. Derogatis LR (1993). Brief Symptom Inventory (BSI). Administration, Scoring, and Procedures Manual, 3rd edn. National Computer Systems : Minneapolis, MN.
7. DuPont RL, Rice DP, Miller SL, Shiraki SS, Rowland CR, Harwood HJ (1996). Economic costs of anxiety disorders. Anxiety 2, 167-172.
8. Greenberg PE, Sisitsky T, Kessler RC, Finkelstein SN, Berndt ER, Davidson JR, Ballenger JC, Fyer AJ (1999). The economic burden of anxiety disorders in the 1990s. Journal of Clinical Psychiatry 60, 427-435.
9. Grosse SD (2008). Assessing cost-effectiveness in healthcare : History of the $50 000 per QALY threshold. Expert Review of Pharmacoeconomics and Outcomes Research 8, 165-178.
10. Hazen AL, Walker JR, Eldridge GD (1996). Anxiety sensitivity and treatment outcome in panic disorder. Anxiety 2, 34-39.
11. Hoch JS, Briggs AH, Willan AR (2002). Something old, something new, something borrowed, something blue : A framework for the marriage of health econometrics and cost-effectiveness analysis. Health Economics 11, 415-430.
12. Katon W, Robinson P, Von Korff M, Lin E, Bush T, Ludman E, Simon G, Walker E (1996). A multifaceted intervention to improve treatment of depression in primary care. Archives of General Psychiatry 53, 924-932.
13. Katon W, Roy-Byrne PP, Russo J, Cowley D (2002). Cost-effectiveness and cost offset of a collaborative care intervention for primary care patients with panic disorder. Archives of General Psychiatry 59, 1098-1104.
14. Katon W, Russo J, Sherbourne CD, Stein MB, Craske MG, Fan M-Y, Roy-Byrne P (2006). Incremental cost-effectiveness of a collaborative care intervention for panic disorder. Psychological Medicine 36, 353-363.
15. Katon W, Von Korff M, Lin E, Simon G, Walker E, Unützer J, Bush T, Russo J, Ludman E (1999). Stepped collaborative care for primary care patients with persistent symptoms of depression : A randomized trial. Archives of General Psychiatry 56, 1109-1115.
16. Katon W, Von Korff M, Lin EH, Walker ED, Simon GE, Bush TM, Robinson P, Russo J (1995). Collaborative management to achieve treatment guidelines. Impact on depression in primary care. Journal of the American Medical Association 273, 1026-1031.
17. Katzelnick DJ, Simon GE, Pearson SD, Manning WG, Helstad CP, Henk HJ, Cole SM, Lin EH, Taylor LH, Kobak KA (2000). Randomized trial of a depression management program in high utilizers of medical care. Archives of Family Medicine 9, 345-351.
18. Kessler RC (2000). Posttraumatic stress disorder : The burden to the individual and to society. Journal of Clinical Psychiatry 61 (Suppl. 5), 4-12, discussion 13-14.
19. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62, 593-602.
20. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51, 8-19.
21. Koenker R, Hallock KF (2001). Quantile regression : An introduction. Journal of Economic Perspectives 15, 143-156.
22. Lave JR, Frank RG, Schulberg HC, Kamlet MS (1998). Cost-effectiveness of treatments for major depression in primary care practice. Archives of General Psychiatry 55, 645-651.
23. Machlin SR, Carper K (2007a). Expenses for Hospital Inpatient Stays, 2004. Statistical Brief No. 164. Agency for Healthcare Research and Quality : Rockville, MD.
24. Machlin SR, Carper K (2007b). Expenses for Office-Based Physician Visits by Specialty, 2004. Statistical Brief No. 166. Agency for Healthcare Research and Quality : Rockville, MD.
25. Mendlowicz MV, Stein MB (2000). Quality of life in individuals with anxiety disorders. American Journal of Psychiatry 157, 669-682.
26. Nixon RM, Wonderling D, Grieve RD (2010). Non-parametric methods for cost-effectiveness analysis : The central limit theorem and the bootstrap compared. Health Economics 19, 316-333.
27. Olfson M, Fireman B, Weissman MM, Leon AC, Sheehan DV, Kathol RG, Hoven C, Farber L (1997). Mental disorders and disability among patients in a primary care group practice. American Journal of Psychiatry 154, 1734-1740.
28. Rabin R, de Charro F (2001). EQ-5D: A measure of health status from the EuroQol Group. Annals of Medicine 33, 337-343.
29. Rollman BL, Belnap BH, Mazumdar S, Houck PR, Zhu F, Gardner W, Reynolds 3rd CF, Schulberg HC, Shear MK (2005). A randomized trial to improve the quality of treatment for panic and generalized anxiety disorders in primary care. Archives of General Psychiatry 62, 1332-1341.
30. Rost K, Nutting P, Smith JL, Elliott CE, DickinsonM(2002). Managing depression as a chronic disease : A randomised trial of ongoing treatment in primary care. British Medical Journal 325, 934-937.
31. Roy-Byrne PP, Craske MG, Stein MB, Sullivan G, Bystritsky A, Katon W, Golinelli D, Sherbourne CD (2005). A randomized effectiveness trial of cognitivebehavioral therapy and medication for primary care panic disorder. Archives of General Psychiatry 62, 290-298.
32. Roy-Byrne P, Craske MG, Sullivan G, Rose RD, Edlund MJ, Lang AJ, Bystritsky A, Welch SS, Chavira DA, Golinelli D, Campbell-Sills L, Sherbourne CD, Stein MB (2010). Delivery of evidence-based treatment for multiple anxiety disorders in primary care : A randomized controlled trial. Journal of the American Medical Association 303, 1921-1928.
33. Roy-Byrne P, Katon W, Cowley D, Russo J (2001). A randomized effectiveness trial of collaborative care for patients with panic disorder in primary care. Archives of General Psychiatry 58, 869-876.
34. Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC (1996). The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. Journal of the American Medical Association 276, 1172-1177.
35. Shaw JW, Johnson JA, Coons SJ (2005). US valuation of the EQ-5D health states : Development and testing of the D1 valuation model. Medical Care 43, 203-220.
36. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar G (1998). The Mini-International Neuropsychiatric Interview (M.I.N.I.) : The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59 (Suppl. 20), 22-33.
37. Simon GE, Ludman E, Rutter CM (2009). Incremental benefit and cost of telephone care management and telephone psychotherapy for depression in primary care. Archives of General Psychiatry 66, 1081-1089.
38. Simon GE, Von Korff M, Rutter CM, Wagner E (2000). Randomized trial of monitoring, feedback, and management of care by telephone to improve treatment of depression in primary care. British Medical Journal 320, 550-554.
39. Stein MB, Heimberg RG (2004). Well-being and life satisfaction in generalized anxiety disorder : Comparison to major depressive disorder in a community sample. Journal of Affective Disorders 79, 161-166.
40. Stein MB, Kean YM (2000). Disability and quality of life in social phobia : Epidemiologic findings. American Journal of Psychiatry 157, 1606-1613.
41. Stein MB, Sherbourne CD, Craske MG,Means-Christensen A, Bystritsky A, Katon W, Sullivan G, Roy-Byrne PP (2004). Quality of care for primary care patients with anxiety disorders. American Journal of Psychiatry 161, 2230-2237.
42. Stinnett AA, Mullahy J (1998). Net health benefits : A new framework for the analysis of uncertainty in cost-effectiveness analysis. Medical Decision Making 18, S68-S80.
43. Sturm R, Unützer J, Katon W (1999). Effectiveness research and implications for study design : Sample size and statistical power. General Hospital Psychiatry 21, 277-283.
44. Sullivan G, Craske MG, Sherbourne CD, Edlund MJ, Rose RD, Golinelli D, Chavira DA, Bystritsky A, Stein MB, Roy-Byrne PP (2007). Design of the Coordinated Anxiety Learning and Management (CALM) study : Innovations in collaborative care for anxiety disorders. General Hospital Psychiatry 29, 379-387.
45. Unützer J, Choi Y, Cook IA, Oishi S (2002a). A web-based data management system to improve care for depression in a multicenter clinical trial. Psychiatric Services 53, 671-673, 678.
46. Unützer J, Katon W, Callahan CM, Williams JWJ, Hunkeler E, Harpole L, Hoffing M, Della Penna RD, Noel PH, Lin EHB, Arean PA, Hegel MT, Tang L, Belin TR, Oishi S, Langston C (2002b). Collaborative care management of late-life depression in the primary care setting. Journal of the American Medical Association 288, 2836-2845.
47. Unützer J, Katon WJ, Russo J, Simon G, von Korff M, Lin E, Walker E, Ludman E, Bush T (2003). Willingness to pay for depression treatment in primary care. Psychiatric Services 54, 340-345.
48. Van Ameringen M, Mancini C, Farvolden P (2003). The impact of anxiety disorders on educational achievement. Journal of Anxiety Disorders 17, 561-571.
49. Vannoy SD, Arean P, Unützer J (2010). Advantages of using estimated depression-free days for evaluating treatment efficacy. Psychiatric Services 61, 160-163.
50. Waghorn GR, Chant DC (2005). Employment restrictions among persons with ICD-10 anxiety disorders : Characteristics from a population survey. Journal of Anxiety Disorders 19, 642-657.
51. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC (2005). Twelve-month use of mental health services in the United States. Results from the National Comorbidity Survey Replication. Archives of General Psychiatry 62, 629-640.
52. Ware JE, Kosinski M, Keller SD (1996). A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Medical Care 34, 220-223.
53. Wells KB (1999). The design of partners in care : Evaluating the cost-effectiveness of improving care for depression in primary care. Social Psychiatry and Psychiatric Epidemiology 34, 20-29.
54. Wells KB, Sherbourne CD, Schoenbaum M, Duan N, Meredith L, Unützer J, Miranda J, Carney M, Rubenstein L (2000). Impact of disseminating quality improvement programs for depression in managed primary care : A randomized controlled trial. Journal of the American Medical Association 283, 212-220.
55. Willan AR, Lin DY (2001). Incremental net benefit in randomized clinical trials. Statistics in Medicine 20, 1563-1574.
56. Wittchen HU (2002). Generalized anxiety disorder : Prevalence, burden, and cost to society. Depression and Anxiety 16, 162-171.